Tag Archives: Research

Pressemitteilungen

Mit MindManager die Herausforderungen der Arbeitswelt von morgen meistern

Spot On MindManager Event beschäftigt sich mit der Arbeitswelt 4.0

Alzenau, 14. Mai 2019 – Die 12. Spot On Veranstaltung, die am 22. Mai in der Opel Arena in Mainz stattfindet, steht ganz im Zeichen der Digitalisierung unserer Arbeitswelt. In ihren Vorträgen beleuchten verschiedene bekannte Experten die Herausforderungen der neuen Arbeitswelt und zeigen auf, wie diese mit Hilfe der geeigneten Prozesse und Werkzeuge wie MindManager® bewältigt werden können. Ab sofort können sich Interessenten für die Veranstaltung anmelden.

In der Keynote fragt sich Dr. Pero Mićić, Gründer und Vorstand der Future Management Group „Wozu braucht die Maschine noch den Menschen?“ und zeigt auf, wie grundlegend und weitreichend die Veränderungen sind, die sich derzeit in der Arbeitswelt vollziehen. Vor welchen Herausforderungen Unternehmen beim Einstieg in die digitale Arbeitswelt konkret stehen und wie sie diesen erfolgreich begegnen können, erläutert Marco Looser von der Management Communication Pool AG. In seinem Beitrag „Arbeitswelt 4.0 – Lösungskonzepte für die anspruchsvolle Reise in die digitale Welt“ zeigt er anhand eines Research Projekts, welches in Zusammenarbeit mit der renommierten Fachhochschule Nordwestschweiz durchgeführt wird, Lösungswege für Unternehmen auf.

Sven Werner von ThyssenKrupp Marine Systems zeigt in seinem Praxisbeispiel die Umsetzung des Spot On Mottos der Arbeitswelt 4.0 und verdeutlicht die Mehrwerte von agilem Prozess- und Projektmanagement mit MindManager bei der Entwicklung von Unterseebooten. Wie immer gibt es diesmal auch einen Fachvortrag eines MindManager Experten sowie die bewährten Expert Stations und die verschiedenen Networking-Möglichkeiten. Zum Abschluss der Veranstaltung sind alle Teilnehmer zu einer Führung durch das Stadion des Erstligisten Mainz 05 eingeladen.

Mehr Informationen, die detaillierte Agenda sowie Anmeldung unter https://go.mindjet.com/SpotOn-Mainz-22.05.2019.html

Über Mindjet MindManager
MindManager vereinfacht das Sammeln, Organisieren und Teilen von Informationen und hilft dadurch Einzelanwendern, Teams und Unternehmen, ihre Arbeit schneller zu erledigen. MindManager stellt Ideen und unstrukturierte Daten in visuellen dynamischen Maps dar und sorgt somit für mehr Verständlichkeit und eine bessere Kontrolle des Zeit- und Arbeitsaufwands. Weltweit nutzen Millionen von Menschen MindManager zum Brainstormen, der Planung und Umsetzung von Projekten sowie der Kommunikation von Wissen und Informationen. MindManager wird von Mindjet angeboten, einem Geschäftsbereich der Corel Corporation. Weitere Informationen erhalten Sie auf www.mindmanager.com

Über Corel
Als eines der weltweit führenden Softwareunternehmen bietet Corel einige der angesehensten und bekanntesten Marken der Branche, darunter MindManager®, CorelDRAW®, Parallels®, ClearSlide®, Pinnacle™ und WinZip®. In unserem gesamten Portfolio bieten die Produkte von Corel den heutigen Wissensarbeitern die Werkzeuge, die sie benötigen, um ein neues Maß an Kreativität, Produktivität und Erfolg zu erreichen.
Weitere Informationen erhalten Sie auf www.corel.com

© 2019 Corel Corporation. Corel, das Corel Logo, das Corel Ballon Logo, CorelDRAW, MindManager, das MindManager Logo und Mindjet, SmartRules, Pinnacle und WinZip sind Marken oder eingetragene Marken der Corel Corporation oder ihrer Tochtergesellschaften in Kanada, den USA und anderen Ländern. ClearSlide ist eine eingetragene Marke von ClearSlide Inc. in Kanada, den USA und anderen Ländern. Parallels ist eine Marke oder eingetragene Marke der Parallels International GmbH in Kanada, den USA und anderen Ländern. Alle anderen hier genannten Marken sind Eigentum ihrer jeweiligen Besitzer. Patente: www.corel.com/patent

Firmenkontakt
Corel GmbH – Mindjet
Pascale Winter
Siemensstraße 30
63755 Alzenau
06023 – 9645508
06023 – 9645-60
pascale.winter@mindjet.com
http://www.mindjet.de

Pressekontakt
Schmidt Kommunikation GmbH
Alexandra Schmidt
Schillerstrasse 8
85521 Ottobrunn
089 60 66 92 22
089 60 66 92 23
alexandra.schmidt@schmidtkom.de
http://www.schmidtkom.de

Die Bildrechte liegen bei dem Verfasser der Mitteilung.

Pressemitteilungen

Asahi Kasei Honorary Fellow Dr. Akira Yoshino Nominated as a Finalist for the European Inventor Award 2019

Düsseldorf, May 7, 2019 – Asahi Kasei Honorary Fellow Dr. Akira Yoshino has been nominated by the European Patent Office (EPO) as a finalist for the European Inventor Award 2019 in the category of „Non-EPO countries“ for his invention and refinement of the lithium-ion battery.

Launched by the EPO in 2006, the European Inventor Award – one of Europe’s most prestigious innovation prizes – annually honors individual or teams of inventors for their contribution towards technical progress, social development, and economic prosperity. It is awarded in the five categories of „Industry“, „Research“, „Non-EPO Countries“, „Small and Medium-Sized Enterprises“, and „Lifetime Achievement“, along with the „Popular Prize“ which is chosen from among the finalists by online voting on the EPO website.

Several innovations and developments from Japan have been recognized with this nomination, such as blue LEDs, immunosuppressant therapy drug, power control system for hybrid automobile, the QR code, and carbon nanotubes. Dr. Yoshino“s development of the lithium-ion battery is the 6th Japanese achievement to earn nomination as a finalist for the award.

Winners are selected from among the three finalist inventors or teams nominated in each of the five categories. Announcement of the winners in each category and the winner of the Popular Prize – where the winner gets chosen by his supporters via online voting – will be made at the award ceremony on June 20, 2019, in Vienna, Austria.

The public is invited to vote for the Popular Prize here.

Developed by Dr. Yoshino in the early 1980s, the lithium-ion battery has been widely adopted in various electronic devices as a safe lightweight rechargeable battery, enhancing portability as the digital age began in the 1990s, ushering in the IT revolution and our current society of mobile connectivity. Furthermore, the lithium-ion battery is playing a growing role in measures to counter global warming, by powering electric vehicles and by enabling the effective storage and use of electricity from unstable sources of renewable energy. As such, the lithium-ion battery will thus continue to be increasingly important for the sustainability of our society.

Asahi Kasei Corporation is a globally active diversified technology company with operations in the Material, Homes, and Health Care business. The Material division encompasses fibers & textiles, petrochemicals, performance polymers, performance materials, consumables, battery separators, and electronic devices. The Homes division provides housing and construction materials to the Japanese market. The Health Care division includes pharmaceuticals, medical devices, and acute critical care devices and systems. With approximately 35,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries and recorded net sales of 15.3 billion Euro in fiscal year 2017.

Asahi Kasei is „Creating for Tomorrow“ with all operations sharing a common mission of contributing to life and living for people around the world.

Company-Contact
Asahi Kasei Europe GmbH
Sebastian Schmidt
Am Seestern 4
40547 Düsseldorf
Phone: +49 (0)211 280 68 139
E-Mail: Sebastian.Schmidt@asahi-kasei.eu
Url: https://www.asahi-kasei.eu/

Press
financial relations GmbH
Henning Küll
Louisenstraße 97
61348 Bad Homburg
Phone: +49 (0) 6172 27159 12
E-Mail: h.kuell@financial-relations.de
Url: http://www.financial-relations.de

Bildquelle: @Asahi Kasei

Pressemitteilungen

CodeCheck: Oeeda erweitert Management mit Head of Science

Ex-Procter & Gamble-Managerin Ruta Almedom leitet neuen Marktforschungsbereich der CodeCheck AG

Berlin/Zürich, 11.04.2019 – Original Pressemitteilung Oeeda (www.oeeda.com), der neue Marktforschungsbereich der CodeCheck AG hat heute die Ernennung von Ruta Almedom zur neuen Head of Science bekannt gegeben. Ruta Almedom wird ab sofort die Leitung der wissenschaftlichen Abteilung der CodeCheck AG übernehmen. CodeCheck (www.codecheck.info) ist Anbieter des gleichnamigen führenden Einkaufsratgebers für Lebensmittel und Kosmetika im deutschsprachigen Raum und gilt als „eines der renommiertesten Portale, wenn es um Auskünfte über Inhaltsstoffe geht“ (Neue Zürcher Zeitung). Almedom folgt auf Mandy Hecht, welche die Leitung des Marktforschungsbereichs Oeeda verantwortet.

Almedom kommt von Procter & Gamble, wo sie in den vergangenen zehn Jahren als Senior Scientist im Bereich Produktforschung für verschiedene Gruppen des Konzerns tätig war. Ruta Almedom spezialisierte sich auf Neurobiologie, Molekularbiologie und Biochemie und promovierte an der Johann Wolfgang Goethe-Universität in Frankfurt am Main.

„Die beliebte CodeCheck-App wird bereits von Millionen moderner Verbraucherinnen und Verbraucher genutzt, die gesunde und nachhaltigkeitsorientierte Lebensstile bevorzugen, Mikroplastik vermeiden wollen oder sich laktosefrei oder glutenfrei ernähren müssen. Zukünftige Märkte und Innovationen kommen an dieser stark wachsenden Zielgruppe nicht mehr vorbei und CodeCheck stellt mit Oeeda einen einmaligen Kanal zur Kommunikation zwischen Herstellern und bewussten Konsumenten her“, erklärt Dr. Ruta Almedom.

„Mit Erkenntnissen aus der CodeCheck-Community bieten wir FMCG-Herstellern und Marketing-Entscheidern umfangreiche, spezialisierte und schnelle Marktforschungs-Dienstleistungen wie zum Beispiel die neuen „Oeeda Category Reports“. Hierfür ist die Einhaltung sehr hoher Qualitätsstandards notwendig, die unsere wissenschaftliche Abteilung sicherstellt. Wir freuen uns sehr, dass wir Ruta Almedom mit ihrer langjährigen Expertise für diese anspruchsvolle Aufgabe gewinnen konnten“, erläutert Dr. Mandy Hecht, Leiterin des Oeeda-Produktbereichs.

Oeeda ist der neue Marktforschungsbereich der CodeCheck AG, Anbieter der CodeCheck-App, dem beliebten Einkaufsratgeber für bewusste Konsumenten im deutschsprachigen Raum mit über 2,5 Millionen registrierten Nutzerinnen und Nutzern. Die CodeCheck-App wird von führenden Medien immer wieder empfohlen.

Hochauflösendes Presse-Bildmaterial zur honorarfreien Nutzung unter:http://bit.ly/Oeeda-New_Head_of_Science-Mediakit

Über OeedaOeeda (www.oeeda.com) ist der neue B2B-Marktforschungsbereich der CodeCheck AG, Anbieter des führenden Einkaufsratgebers für Lebensmittel und Kosmetika im deutschsprachigen Raum mit über 2,5 Millionen registrierten Nutzerinnen und Nutzern. Oeeda bietet FMCG-Herstellern, Marketing-Entscheidern und dem Einzelhandel umfangreiche, spezialisierte und schnelle Marktforschung-Dienstleistungen im Zusammenhang mit der stark wachsenden Zielgruppe der bewussten Konsumentinnen und Konsumenten (z.B. vegane und vegetarische Lebensstile, Verzicht auf laktose- und glutenhaltige Lebensmittel). Beliebte Produkte sind die „Oeeda Category Reports“ mit direkten Verbraucheranalysen, qualitatives Verbraucher-Feedback zu mehreren Millionen Produkten und das derzeit umfangreichste Panel bewusster Konsumenten im DACH-Raum für viele Anwendungsbereiche – von Design-Tests bis zu klassischen mobilen Umfragen.

CodeCheck App Download:Apple iOS: https://itunes.apple.com/de/app/codecheck-lebensmittel-kosmetik/id359351047

Google Android: https://play.google.com/store/apps/details?id=ch.ethz.im.codecheck

Unternehmenskontakt Oeeda:
CodeCheck AG
Unternehmenskommunikation
Joachim M. Guentert
Jenatschstrasse 1
CH-8002 Zürich
Tel.: +41 44 450 25 41
E-Mail: joachim.guentert@codecheck.info

Oeeda ( www.oeeda.com) ist der neue B2B-Marktforschungsbereich der CodeCheck AG, Anbieter des führenden Einkaufsratgebers für Lebensmittel und Kosmetika im deutschsprachigen Raum mit über 2,5 Millionen registrierten Nutzerinnen und Nutzern.

Oeeda bietet FMCG-Herstellern, Marketing-Entscheidern und dem Einzelhandel umfangreiche, spezialisierte und schnelle Marktforschung-Dienstleistungen im Zusammenhang mit der stark wachsenden Zielgruppe der bewussten Konsumentinnen und Konsumenten (z.B. vegane und vegetarische Lebensstile, Verzicht auf laktose- und glutenhaltige Lebensmittel).

Beliebte Produkte sind die „Oeeda Category Reports“ mit direkten Verbraucheranalysen, qualitatives Verbraucher-Feedback zu mehreren Millionen Produkten und das derzeit umfangreichste Panel bewusster Konsumenten im DACH-Raum für viele Anwendungsbereiche – von Design-Tests bis zu klassischen mobilen Umfragen.

Kontakt
CodeCheck AG
Joachim Guentert
Jenatschstrasse 1
8002 Zürich
+41 44 450 25 41
joachim.guentert@codecheck.info
http://www.codecheck.info

Die Bildrechte liegen bei dem Verfasser der Mitteilung.

Internationales Pressemitteilungen

Interventional Radiology Products Market worth $8.02 Billion by 2021 | Know The Key Market Drivers

According to a new market research report „Interventional Radiology Products Market by type (Stents, Catheters, IVC Filter, Accessories), Procedure Type (Angioplasty, Angiography, Biopsy, Thrombolysis, Embolization), Applications (Oncology, Cardiology, Urology & Nephrology) – Forecast to 2021“, published by MarketsandMarkets, the global market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8% from 2016 to 2021.

Don’t miss out on business opportunities in Interventional Radiology Products Market. Speak to our analyst and gain crucial industry insights that will help your business grow:
https://www.marketsandmarkets.com/speaktoanalyst.asp?id=67681703

The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. However, new players in the interventional radiology sector face significant entry barriers; this is a key challenge in the market.

Based on type, the market is segmented into stents, catheters, IVC filters, hemodynamic flow alteration devices, angioplasty balloons, thrombectomy systems, embolization devices, biopsy needles, and accessories. In 2016, the stents segment is expected to dominate the global interventional radiology products market. The key factors driving the growth of the interventional radiology stents market are the growing geriatric population and increasing incidence of cardiovascular diseases around the world.

Browse and in-depth TOC on “ Interventional Radiology Products Market

79 – Tables
37 – Figures
144 – Pages

View more detailed TOC @ https://www.marketsandmarkets.com/Market-Reports/interventional-radiology-product-market-67681703.html Based on procedure, the market is segmented into angioplasty, angiography, embolization, thrombolysis, biopsy & drainage, vertebroplasty, nephrostomy, and other applications. In 2016, the angiography segment is expected to account for the largest share of this market. The growing demand for minimally invasive procedures and increasing geriatric population are the key factors in this segment.

Based on region, the global interventional radiology products market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). In 2016, North America is expected to account for the largest share of the market. The rising incidence of chronic diseases (CVD), the increasing demand for minimally invasive procedures, and availability of reimbursement for minimally invasive products in this region are the major factors contributing to the growth of this market.

Request for Free Sample Report @ https://www.marketsandmarkets.com/requestsample.asp?id=67681703

Key players in the interventional radiology products market include Abbott Vascular (US), Boston Scientific Corporation (US), Medtronic plc (Ireland), Cardinal Health (US), B. Braun Melsungen AG (Germany), CR Bard (US), Biosensor International Group Ltd. (Singapore), Stryker Corporation (US), Terumo Corporation (Japan), and Cook Medical Inc. (US).

Browse Adjacent Markets @ Medical Devices Market Research Reports & Consulting

About MarketsandMarkets ™

MarketsandMarkets ™ provides quantified B2B research on 30,000 high growth opportunities / threats 70% to 80% of worldwide companies‘ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets ™ for their painpoints around

Our 850 fulltime analyst and SMEs at MarketsandMarkets ™ are following the „Growth Engagement Model – GEM“. The GEM aims to identify new opportunities, identify the most important customers, write attack, avoid and defend strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets ™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets ™ is going to spend more than 10,000 companies this year for their revenue planning and help them make their innovations / disruptions early to the market.

MarketsandMarkets‘ flagship competitive intelligence and market research platform, ‚Knowledge Store‘, joins over 200,000 markets and entire value chains for the understanding of the marketplace.

Contact:

Mr. Shelly Singh
MarketsandMarkets ™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
United States: 1-888-600-6441
Email: sales@marketsandmarkets.com

Aktuelle Nachrichten Internationales Pressemitteilungen

Increasing Prevalence of Chronic Diseases Driving Growth In Enteral Feeding Devices Market

According to a new market research Enteral Feeding Devices Market by Type (Feeding Pump, Feeding Tube, Giving Set, Enteral Syringes), Age Group (Adult, Pediatric), Application (Oncology, Gastroenterology, Diabetes), End User (Hospital, Home Care) – Global Forecast to 2022″, published by MarketsandMarkets™, the market is expected to reach USD 3.19 Billion by 2022 from an estimated USD 2.39 Billion in 2017, at a CAGR of 6.0% during the forecast period.

Browse 281 market data Tables and 48 Figures spread through 304 Pages and in-depth TOC on „Enteral Feeding Devices Market“.

Factors such as the increasing prevalence of chronic diseases, rising geriatric population, rising incidence of preterm births, growing demand for enteral feeding devices in the home care sector, and the shift from parenteral to enteral nutrition are the key drivers of the Enteral Feeding Devices Market. Furthermore, the rising demand for user-friendly feeding devices and technological advancements are contributing to the growth of this market. However, the complications associated with the use of enteral feeding devices and the insufficient reimbursements for enteral nutrition are some of the major challenges currently at play in the market.

By product, the enteral feeding pumps segment accounted for the largest share of the market

On the basis of products, the enteral feeding pumps segment accounted for the largest share of the Enteral Feeding Devices Market, in 2016. This can be attributed to the low risk of complications with the use of feeding pumps, enhanced portable pump designs, and the increasing use of pumps in home care settings.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=183623035

The adults segment dominated the market in 2016

Based on age group, the adults segment accounted for the largest share of the Enteral Feeding Devices Market. The large share can be attributed to the increasing incidence and prevalence of chronic diseases like cancer, diabetes, neurological disorders, and inflammatory bowel syndrome that result in malnutrition along with the rapid rise in the aging population.

The oncology segment is expected to grow at the highest CAGR during the forecast period

By application, the Enteral Feeding Devices Market is segmented into oncology, gastroenterology, diabetes, neurology, hyper metabolism, and other applications. The oncology segment is expected to grow at the highest CAGR owing to the increasing incidence and prevalence of cancer across the globe and the need for clinical nutrition in such patients.

North America dominated the market in 2016

North America accounted for the largest share of the Enteral Feeding Devices Market in 2016, followed by Europe. This regional segment shows significant market growth opportunities owing to the high adoption of enteral feeding devices, increasing prevalence of chronic diseases, presence of many large hospitals, and the development of innovative products. Moreover, a number of major global players are based in the US.

The prominent players in the Enteral Feeding Devices Market are Fresenius Kabi (Germany), Halyard Health (US), Medtronic (Ireland), B. Braun (Germany), Abbott (US), C.R. Bard (US), Boston Scientific (US), Cook Medical (US), CONMED (US), Nestlé (Switzerland), Danone (France), Moog (US), Vygon (France), and Applied Medical Technology (US).

Medical Devices Market Research Reports & Consulting

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies‘ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the „Growth Engagement Model – GEM“. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write „Attack, avoid and defend“ strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, „Knowledge Store“ connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Shelly Singh

MarketsandMarkets™ INC.

630 Dundee Road

Suite 430

Northbrook, IL 60062

USA: +1-888-600-6441

Email: sales@marketsandmarkets.com

Research Insight: https://www.marketsandmarkets.com/ResearchInsight/enteral-feeding-device-market.asp

Pressemitteilungen

www.biolitec.com: New website presents modern medical laser therapies

biolitec® has launched a new website – Functional modern design – Worldwide leading developer and manufacturer of minimally invasive laser therapies – Successful research and development in areas such as phlebology and proctology – 10 years ELVeS®

www.biolitec.com: New website presents modern medical laser therapies

biolitec®_Homepage_en (Source: @biolitec biomedical technology gmbh)

Jena, May 22, 2018 – The developer and manufacturer of medical laser systems for minimally-invasive therapies, biolitec biomedical technology GmbH, has unveiled its new online presence. A modern layout now stands for an adapted innovative website functionality and a better overview of the company’s versatile product and application areas: Thanks to the new tile design, the entire website is structured in a way that the extensive range of medical applications and laser systems of biolitec® can be recognized at first glance.

This principle of fast recognition can be found both in the subject area for doctors and for patients. This, for instance, gives doctors an immediate overview of all biolitec® lasers. For example, if the visitor clicks on the „Dual 100“ tile, he can, due to the simple depiction, see all the therapeutic areas in which this laser can be used.

The same applies to patients: The respective therapy subpages under the menu item „patients“ lead directly to the patient websites adapted to the special needs of patients, such as www.info-varicose-vein.com, which can also be accessed as independent websites.

Founded more than 30 years ago, biolitec® has become one of the world’s leading companies in the field of minimally invasive laser therapies – due to continuous research and development of its products. Thanks to subsidiaries, including in South America and Asia, its innovative laser systems and methods are available for a wide range of applications for gentle and low-intensity treatment options all around the globe. biolitec® lasers are often innovative alternatives to conventional treatment methods in phlebology, proctology, thoracic surgery, urology, gynecology, ENT and orthopedics.

For 10 years now, the unique ELVeS® Radial® 2-ring laser fiber of biolitec®, with its efficient and simple technology, has been convincing in the treatment of varicose veins.

As a result of intensive research, biolitec® has always been able to offer the most modern possibilities in minimally invasive laser medicine. The new LEONARDO® laser family by biolitec® includes the only laser systems available on the market in which two wavelengths can be adjusted and used independently and continuously during the treatment. The universal applicability of the lasers in various fields of application is unique.

Further information on all products and applications of the laser therapies by biolitec® is available directly on the new website www.biolitec.com.

About biolitec
biolitec® is one of the world“s leading medical technology companies in the field of laser applications and the only provider which possesses all the relevant core competences in the field of photodynamic therapy (PDT) – photosensitizers, lasers and fibre optic cables. Besides laser-supported treatment of cancers with the drug Foscan®, biolitec® researches and markets above all minimally invasive, gentle laser procedures.
ELVeS® Radial® (Endo Laser Vein System) is the world“s most-used laser system to treat venous insufficiency. The LEONARDO® diode laser from biolitec® is the first universally applicable medical laser which has a combination of two wavelengths, 980nm and 1470nm, and which can be used across disciplines. The innovative contact fibre XCAVATOR® in conjunction with the LEONARDO® DUAL 200 Watt laser allows in urology a gentle treatment of e.g. benign prostate enlargement (BPH). The light-weight LEONARDO® Mini laser weighing only 900 g was developed especially for mobile application on site. Gentle laser applications in the fields of proctology, ENT, gynecology, thorax surgery and pneumology are also part of biolitec®“s field of business. More information available at www.biolitec.com

Contact
biolitec biomedical technology GmbH
Joern Gleisner
Otto-Schott-Str. 15
07745 Jena
Phone: +49 (0) 3641 / 51953-36
Fax: +49 (0) 6172 / 27159-69
E-Mail: joern.gleisner@biolitec.com
Url: http://www.biolitec.com

Aktuelle Nachrichten Auto/Verkehr Computer/Internet/IT Energie/Natur/Umwelt Essen/Trinken Finanzen/Wirtschaft Gesellschaft/Politik Gesundheit/Medizin Pressemitteilungen Reisen/Tourismus

Global Oligonucleotide Synthesis Market – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

 

Global Oligonucleotide Synthesis Market: By Product (Synthesized oligonucleotides, Reagents, Equipment), By Application (Diagnostics, Research, Therapeutics), By End-Users (Diagnostic Laboratories, Research Institutes, Biotechnology & Pharmaceutical Companies), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013 to 2017 and Forecast 2018 to 2024

 

Global oligonucleotide synthesis market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Oligonucleotide Synthesis Market

Oligonucleotide Synthesis is synthesis of short fragments of the nucleic acids which has a defined chemical structure. This process of chemical synthesis enables provide a rapid access to the custom-made oligonucleotides. The building blocks are coupled sequentially which further helps in growing the customized oligonucleotide chain.

 

Market Dynamics: Oligonucleotide Synthesis Market

The increase in adoption of advanced technologies are expected to increase the growth of oligonucleotide synthesis market. The surge in initial investments in research and development, companies focused on novel technologies are anticipated to fuel the growth of oligonucleotide synthesis market. Furthermore, these R&D activities are adding scope for the advent of new products which is likely to enhance the growth of the oligonucleotide synthesis market, providing opportunities to the manufactures. The increasing government support in developing technologies such as the oligonucleotide synthesis technology and the genomic technologies is enriching the growth of the market. Personalized medicine is playing a vital role, expected to add fuel for the growth of oligonucleotide synthesis market. However, the stringent government regulations in approval of oligonucleotide-based therapeutics are expected to hamper the growth of the market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Oligonucleotide Synthesis Market

Oligonucleotide synthesis market is segmented based on the product, application, and end-user

Based on the product, the market is segmented into the following:

  • Synthesized oligonucleotides
    • DNA oligonucleotides
    • RNA oligonucleotides
    • Others
  • Reagents
  • Equipment

Based on the application, the market is segmented into the following:

  • Diagnostics
  • Research
  • Therapeutics

Based on the end-user, the market is segmented into the following:

  • Diagnostic Laboratories
  • Research Institutes
  • Biotechnology & Pharmaceutical Companies

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Oligonucleotide Synthesis Market

Geographically, global oligonucleotide synthesis market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America oligonucleotide synthesis market is dominant and is expected to hold its position over the forecasted period. The soaring advancements in the healthcare sector, increased investments in biotechnology is expected to witness the growth of the market. The increasing R&D activities, sophisticated infrastructure expected to fuel the market. The Asia Pacific oligonucleotide synthesis market is expected to accelerate the growth in the forecasted period owing to emerging economies such as China and India, which enables increase the growth of oligonucleotide synthesis market.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Oligonucleotide Synthesis Market

Some of the players in the global oligonucleotide synthesis market include:

  • Thermo Fisher Scientific Inc. (U.S)
  • Integrated DNA Technologies, Inc. (U.S)
  • Sigma-Aldrich Corporation (U.S)
  • GE Healthcare (U.S)
  • Eurofins Genomics (Germany)
  • Nitto Denko Avecia Inc. (Japan)
  • Agilent Technologies Inc. (U.S)

Notable Market Developments: Oligonucleotide Synthesis Market

  • In October 2017, Integrated DNA Technologies has acquired oligonucleotide manufacturing business of GeneWorks Pty Ltd. (GeneWorks) in Australia.

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/oligonucleotide-synthesis-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

 

 

 

 

Computer/Internet/IT Gesundheit/Medizin Pressemitteilungen Telekommunikation Wissenschaft/Forschung

Diese 4 Anwendungen zeigen das Potenzial von Big Data und Medizin

Potenzial von Big Data

Big-Data-Technologien erlauben es, aus enormen Datenbergen in kürzester Zeit neueste Erkenntnisse zu gewinnen. Lesen Sie weiters, welche Vorteile Big Data spezifisch in der Medizin bietet.  Erfahren Sie anhand von 4 Beispielen mehr über das riesige Potenzial von Big Data. read more »

Pressemitteilungen

Brussels, May 23: Scientific Conference epiXchange2018

Seven large EU-funded projects have joined forces – epiXchange 2018 brings together Europe’s best brains to pave the way for future epilepsy research.

Brussels, May 23: Scientific Conference epiXchange2018

Scientific Conference epiXchange 2018, May 23, 2018, Brussels

Around 50 million people worldwide suffer from epilepsy, making it one of the most common neurological diseases. To decrease this figure and pave the way for future ground-breaking epilepsy research, seven large EU-funded projects have joined forces. epiXchange 2018 is a unique global community building event, designed to gather a critical mass of epilepsy researchers to exchange about latest progress in research aiming to improve the way epilepsy is diagnosed and treated and thereby increase the quality of life of affected people. Six of these projects were funded through the 7th Framework Programme (FP7) which provided total funding of EUR 52 million.

Despite a great progress in the management of epilepsy, 30-40% of epilepsy patients are refractory to all available medications.
Moreover, about 50% of children with epilepsy suffer from epilepsy-related co-morbidities, including developmental delay, learning disabilities, and autism spectrum disorder. Diagnostics is another issue.
„Diagnosis of epilepsy is really difficult,“ explained Prof. David Henshall, coordinator of the epiXchange 2018 co-organising EpimiRNA project. „Seizures are the main clinical symptom for the disease but it is very rare that a doctor will witness the patient having a seizure.“

New innovative solutions to diagnose and treat epilepsy

As published in HORIZON – The EU Research & Innovation Magazine on February 12, one of the major results from the epiXchange projects is the development of biomarkers for epilepsy diagnosis. Identifying biomarkers and changes to brain structures may ultimately lead to new treatments.
„Combining biomarkers is key,“ said Prof. Merab Kokaia, coordinator of the co-organising EPITARGET project. „It could make treatment more personalised in the years to come. Another interesting result as published in HORIZON on April 6 is the fact that delaying epilepsy onset through preventive medication in children with related disorders could reduce the impact on development of epilepsy and other related symptoms.
„If you have a brain malformation… there is nothing you can do to revers it. But… if you can prevent epilepsy from aggravating the situation you can improve the clinical status of these patients“, said Renzo Guerrini, coordinator of the co-organising DESIRE project.
Efforts have been made to pin down the genetics behind the disorders. Blood samples of babies at four key moments – at birth, when the EEG first begins to pick up problems, when seizures begin and at two years of age may help us to develop new drugs.
„We have a very, very unique situation. For the first time we have access to the molecular story before epilepsy“, said Prof. Sergiusz Jozwiak, coordinator of the co-organising EPISTOP project.

These findings and many others will be showcased at epiXchange. To boost the impact of the event, the epiXchange partners are preparing a white paper, presenting the current state of the art in epilepsy research, major bottlenecks and recommendations to shape the way for further research breakthroughs, to move forward to new ways of treatment and to bring research results closer to clinical application.

Five major areas

The epiXchange 2018 scientific conference focuses on five major themes in epilepsy research:

Genetics:
Development of novel treatment strategies based on optogenetics, gene and stem cell therapies.

Therapeutics:
Development of effective epileptogenic therapeutics, many of which face different kinds of bottlenecks e.g. regulatory hurdles.

Biomarkers:
Identification of new biomarkers in blood, peripheral organs, brain tissue, electrophysical data, behavioural data and imaging data, in order to develop novel preventive strategies in at-risk patients.

Biobanks and databases:
Integration of Biobanks and databases into clinical care to facilitate preclinical research. A collaborative approach as foundation for the future of epilepsy research and other disease model biobanks.

Co-morbidities:
Exploration of the mechanisms underlying bi-directional relations between epilepsy and neurological co-morbidities to reduce the high burden of co-morbidities in epilepsy.

epiXchange 2018 is is a dissemination activity of the FP7 funded projects DESIRE, EpimiRNA, EpiTarget and EPISTOP and is open for scientists, EC representatives, industries and other stakeholders from the epilepsy community as well as the press.

epiXchange 2018 key data
Organisers: DESIRE, EpimiRNA, EPISTOP and EpiTarget; Scientific contributions by EpiCare, EpiPGX and Epixchange
Venue: THE EGG, Brussels, www.theeggbrussels.com
Date: May 23, 2018
Homepage: www.epiXchange2018.eu
Twitter: www.twitter.com/epiXchange
Facebook: www.facebook.com/epiXchange2018/

Seven large EC-funded projects on epilepsy co-organise this conference to disseminate project results and discuss the future of epilepsy research in the EU and worldwide.

Six of these projects were funded through the 7th Framework Programme (FP7) which provided total funding of EUR 52 million.

Four of the projects (DESIRE, EpimiRNA, EPISTOP and EpiTarget), still ongoing FP7 collaborative research projects, are co-financing the event. Scientific contributions are provided by partners from EpiCare, an ongoing reference network project, as well as EpiPGX (FP7 collaborative research project) and Epixchange (FP7 MSCA ITN project), which are now finished.

Contact
ARTTIC S.A.S
Sebastian Vinzenz Gfäller
Oskar-von-Miller-Ring 29
80333 München
Phone: +49-89 248 83 03 -36
E-Mail: gfaeller@arttic.eu
Url: http://www.arttic.eu

Pressemitteilungen

Fingerprint Sensors Market | Research Growth by Manufacturers, Regions, Type and Application, Forecast Analysis to 2018-2026 by Acumen Research and Consulting

„Fingerprint Sensors Market „ is the latest addition to Acumen Research and Consulting industry research reports collection.

This research study on the Global Fingerprint Sensors Market offers detailed and insightful information on major regional markets and related sub-markets. The information is gathered via both, but not limited to, extensive secondary research and primary research. The major secondary data sources referred for collecting information include industry journals, white papers, databases, company reports, and up-to-date press releases among others. The study also comprises factors driving and inhibiting the development of fingerprint sensors market. The key opportunity areas and trends prevalent in this market are also been compiled in this study. The current size of this market and its predicted market size by the end of forecast period have been highlighted through this study.

Download Table of Content@ https://www.acumenresearchandconsulting.com/tentative-table-of-content/478

The report has been studied in terms of key market segments and sub-segments. The information on currently leading market segments and sub-segments and the reasons for this growth have been emphasized in the scope of this study. An extensive analysis of fingerprint sensors market has been encapsulated on the basis of estimations of key market segments in the forecast horizon. In addition, the technological developments that took place in the market and those predicted to take place in coming years have also been outlined through this study.

The projections presented in this study on fingerprint sensors market have been made by analyzing market’s future potential and prevalent trends. The market’s growth in various geographies has been studied in detail under this report. The top regions in this market and the reasons for the growth in that particular region have been outlined in the report. Further, the report presents competitive landscape of the fingerprint sensors market, covering information on the market share/positioning analysis of leading players in the market. Under this section, the prime strategies of key players, their strengths and weaknesses, and contributions in market growth are discussed. These players are also evaluated on the basis of attributes such as revenue, gross, product overview, and contact information.

Report Coverage

Market Fingerprint Sensors Market
Analysis Period 2014 – 2024
Historic Data 2014 – 2015
Base Year 2016
Forecast Data 2017 – 2024
Market Stratification Type, Application, Material, Sensor Technology, Geography
Regional Scope North America, Europe, Asia-Pacific, Latin America, Middle East and Africa (MEA)
Report Coverage Market Trends, Drivers, Restraints, Porter’s Five Forces Analysis, Competitive Analysis, Player Profiling, Value Chain Analysis

Our expert team will assist and customize the report so that it best fit your exact requirement, Click Here@ https://www.acumenresearchandconsulting.com/request-customization/478

The major market segments of global fingerprint sensors market are as below:

Market By Type

Swipe sensor

Touch sensor

Area sensor

Market By Application

Law enforcement

Banking & finance

Mobile devices

Government, military & defense

Others

Market By Material

Optical prism

Sapphire

Adhesive

Piezoelectric material

Others

Market By Sensor Technology

Capacitive sensor

o Passive capacitance

o Active capacitance

Optical sensor

Ultrasonic sensor

Thermal sensor

Others

Market By Geography

North America

o US

o Canada

o Mexico

Europe

o UK

o Germany

o France

o Rest of Europe

Asia-Pacific

o China

o Japan

o India

o Australia

o Rest of Asia-Pacific

Latin America

o Brazil

o Rest of Latin America

Middle East and Africa (MEA)

o South Africa

o Saudi Arabia

o Rest of MEA

Market Players

The fingerprint sensor market is distinguished by low competition and various application areas. The major players operating in the global fingerprint sensor market include IDEX ASA, Fingerprint Cards AB, Synaptics Incorporated, Vkansee Technology Inc., Cross Match Holdings, Inc., and Integrated Biometrics, Inc among others. Countries such as the U.S., U.K., China, Germany, and South Korea hold large market share in the fingerprint sensor market. Also, there are numerous collaborations occurring between mobile device and fingerprint sensor manufacturers.

Inquiry Before Buying@ https://www.acumenresearchandconsulting.com/inquiry-before-buying/478

Buy this premium research report@ https://www.acumenresearchandconsulting.com/buy-now/0/478

Would like to place an order or any question, please feel free to contact at sales@acumenresearchandconsulting.com

About Us

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to make fact based decisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.